Literature DB >> 14432192

Studies on the metabolism of isoniazid. l. Development and application of a fluorometric procedure for measuring isoniazid in blood.

J H PETERS.   

Abstract

Entities:  

Keywords:  SPECTROPHOTOMETRY

Mesh:

Substances:

Year:  1960        PMID: 14432192     DOI: 10.1164/arrd.1960.81.4.485

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  7 in total

Review 1.  FLUORESCENCE OF SOLUTIONS: A REVIEW.

Authors:  R T WILLIAMS; J W BRIDGES
Journal:  J Clin Pathol       Date:  1964-07       Impact factor: 3.411

2.  The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine.

Authors:  G A Ellard; P T Gammon; S M Wallace
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

3.  Pulmonary tuberculosis in patient on intermittent haemodialysis.

Authors:  C S Ogg; P A Toseland; J S Cameron
Journal:  Br Med J       Date:  1968-05-04

4.  Renal and biliary disposition of dapsone in the dog.

Authors:  J T Biggs; A K Uher; L Levy; R D Gordon; J H Peters
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

5.  A VERTICAL DIFFUSION METHOD FOR THE MICROBIOLOGICAL ASSAY OF ISONIAZID.

Authors:  J LLOYD; D A MITCHISON
Journal:  J Clin Pathol       Date:  1964-11       Impact factor: 3.411

6.  Effects of isoniazid (INH) on the BCG-induced local immune response after intravesical BCG therapy for superficial bladder cancer.

Authors:  M J Stassar; P D Vegt; P A Steerenberg; A P van der Meijden; H D Meiring; M Dessens-Kroon; H G Geertzen; W den Otter
Journal:  Urol Res       Date:  1994

7.  The penetration of dapsone, rifampicin, isoniazid and pyrazinamide into peripheral nerves.

Authors:  B W Allen; G A Ellard; P T Gammon; R C King; A C McDougall; R J Rees; A G Weddell
Journal:  Br J Pharmacol       Date:  1975-09       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.